Preliminary study on the efficacy and safety of lamivudine and interferon α therapy in decreasing serum HBV DNA level in HBV positive transgenic mice during pregnancy

Journal of Medical Virology

Volumn 76, Issue 2, 2005, Pages 203-207

  Li, Duan ^a   Xu, De Zhong ^a   Choi, Bernard C K ^b,c   Men, Ke ^a   Zhang, Jing Xia ^a   Lei, Xiao Ying ^a   Yan, Yong Ping ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Antiviral therapy; Hepatitis B virus; Intrauterine infection; Transgenic mice

Indexed keywords

ALPHA INTERFERON; INTERFERON ALPHA1B; LAMIVUDINE; UNCLASSIFIED DRUG; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; FEMALE; FETUS; HEPATITIS B; HEPATITIS B VIRUS; INTRAUTERINE INFECTION; MATERNAL SERUM; MOUSE; NEWBORN; NONHUMAN; PERINATAL DRUG EXPOSURE; PREGNANCY; PROGENY; RISK FACTOR; STATISTICAL SIGNIFICANCE; TRANSGENIC MOUSE; VIREMIA; VIRUS TITRATION;

ANIMALS; ANTIVIRAL AGENTS; DISEASE MODELS, ANIMAL; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; INTERFERON-ALPHA; LAMIVUDINE; MICE; MICE, TRANSGENIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIREMIA;

EID: 17844401188     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20353     Document Type: Article

References (23)

1. Akbar SM, Onji M. 1998. Hepatitis B virus (HBV)-transgenic mice as an investigative tool to study immunopathology during HBV infection. Int J Exp Pathol 79:279-291.
2. Brocklehrust P, Volmink J. 2002. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev 2:CD003510.
3. Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, Hayani K, Handelsman E, Smeriglio V, Hoff R, Blattner W. 2002. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 29:484-494.
4. Fazle A, Morikazu O. 1998. Hepatitis B virus (HBV)-transgenic mice as an investigative tool to study immunopathology during HBV infection. J Exp Path 79:279-291.
5. Fischer KP, Gutfreund KS, Tyrrell DL. 2001. Lamivudine resistance in hepatitis B: Mechanisms and clinical implications. Drug Resist Updat 4:118-128.
6. Grosch-Worner I, Schafer A, Obladen M, Maier RF, Seel K, Feiterna-Sperling C, Weigel R. 2002. An effective and safe protocol involving zidovudine and caesarean section to reduce vertical transmission of HIV-1 infection. AIDS 14:2903-2911.
7. Guanguan S, Nianfeng Z, Suhua F, Danhong Y. 2002. Observation on efficacy and safety of lamivudine in treatment of chronic hepatitis B patients with pregnancy. Chinese Hepatology 7:84-86.
8. Guidotti LG, Guilhot S, Chisari FV. 1994. Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and independent pathways. J Virol 68:1265-1270.
9. Julander JG, Sidwell RW, Morrey JD. 2002. Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus. Antiviral Res 55:27-40.
10. Kajino K, Kamiya N, Yuasa S, Takahara T, Sakurai J, Yamamura K, Hino O. 1997. Evaluation of anti-hepatitis B virus (HBV) drugs using the HBV transgenic mouse: Application of the semiquantitative polymerase chain reaction (PCR) for serum HBV DNA to monitor the drug efficacy. Biochem Biophys Res Commun 241:43-48.
11. Kazim N, Wakil SM, Khan CA, Hasnain SE, Sarin SK. 2002. Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Lancet 359:1488-1489.
12. Levin ED, Brunssen S, Wolfe GW, Harry GJ. 2004. Neurobehavioral assessment of mice after developmental AZT exposure. Neurotoxicol Teratol. 26:65-71.
13. Little BB, Bawdon RE, Christmas JT, Sobhi S, Gilstrap LC. 1989. Pharmacokinetics of zaidothymidine during late pregnancy in Long-Evans rats. Am J Obstet Gynecol 161:732-734.
14. Moodley J, Moodley D, Pillay K, Coovadia H, Saba J, van Leeuwen R, Goodwin C, Harrigan PR, Moore KH, Stone C, Plumb R, Johnson MA. 1998. Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovidine in human immunodeficiency virus type 1-infected pregnant women and their offspring. J Infect Dis 178:1327-1333.
15. Morrey JD, Korba BE, Sidwell RW. 1998. Transgenic mice as a chemotherapeutic model for hepatitis B virus infection. Antivir Ther 3:59-68.
16. Morrey JD, Bailey KW, Korba BE, Sidwell RW. 1999. Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine. Antiviral Res 42:97-108.
17. Nagahata T, Araki K, Yamamura K, Matsubara K. 1992. Inhibition of intrahepatic hepatitis B virus replication by antiviral drugs in a novel transgenic mouse model. Antimicrob Agents Chemother 36:2042-2045.
18. Olivero OA, Fernandez JJ, Antiochos BB, Wagner JL, St. Claire ME, Poirier MC. 2002. Transplacental genotoxicity of combined antiretroviral nucleoside analogue therapy in Erythrocebus patas monkeys. J Acquir Immune Defic Syndr 29:323-329.
19. Venerosi A, Valanzano A, Alleva E, Calamandrei G. 2001. Prenatal exposure to anti-HIV drugs: Neurobehavioral effects of zidovudine (AZT)+lamivudine (3TC) treatment in mice. Teratology 63:26-37.
20. Xiong YL, Jia YZ, Wang HM, Liu GZ, Ren H, Zhou Z, Zhang JF. 2001. Hepatitis B virus transgenic mice for the model of anti-hepatitis B virus drugs study. Chin J Hepatol 9:19-21.
21. Xu DZ, Yan YP, Zou S, Choi BC, Wang S, Liu P, Bai G, Wang X, Shi M, Wang X. 2001. Role of placental tissues in the intrauterine transmission of hepatitis B virus. Am J Obstet Gynecol 185:981-987.
22. Xu DZ, Yan YP, Choi BC, Xu JQ, Men K, Zhang JX, Liu ZH, Wang FS. 2002. Risk factors and mechanism of transplacental transmission of hepatitis B virus: A case-control study. J Med Virol 67:20-26.
23. Zonneveld M, Nunen AB, Niesters HG, Man RA, Schalm SW, Janssen HL. 2003. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 10:294-297.